Talking About the Real Thing

Talking About the Real Thing

My most recent article focused on issues surrounding imposter government agents. This week, let’s focus on the real thing. 

Let’s say a U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) agent comes by and says, “Because it would interfere with my investigation, I ask that you not tell anyone that I contacted you.”

Or perhaps you receive a grand jury subpoena that includes this wording: “The United States Attorney requests that you do not disclose the existence of this subpoena. Any such disclosure would impede the investigation being conducted and thereby interfere with the enforcement of the law.”

Either may mistakenly cause you to think you can’t immediately call your counsel and tell them about the contact – which you should. 

Obviously, obstructing an investigation is a big deal. If you follow the news, you know that getting in trouble for obstructing an investigation is often more likely to get a person in trouble than the underlying conduct.

I’ve been fortunate in that so far, no client I’ve been representing on a health fraud matter has ever faced jail time for the alleged fraud. But I did have one physician I represented on a fraud investigation who went to jail for something OTHER than the alleged fraud. I only represented him in the fraud investigation; he had other counsel for his criminal trial. The fraud investigation involved the teaching physician rule.

We convinced the government to drop that investigation. Unfortunately, however, early on in the investigation, the doctors were slated to meet individually with the investigators. The night before talking with the investigators, the doctors all met. I totally understand their intention: they wanted to make sure their recollections were accurate. In their minds, they were acting honestly and appropriately.

But the agents and the government saw things very differently. In the eyes of the government, “making sure you have your facts straight” can easily be viewed as a form of obstruction of justice. You always want to avoid talking about the substance of an investigation with anyone other than your counsel. 

But talking about the substance of the investigation is incredibly different than talking about the process. Telling someone that you’ve been contacted by an agent is entirely permissible.

I would recommend you not talk about what you told the agent to anyone other than counsel, but the fact that there is a government investigation isn’t protected information, with a very narrow exception for certain acts of terrorism and bank fraud investigations.

In a health fraud investigation, if you so choose, you can rent the Goodyear Blimp to publicize the fact that there’s an investigation. More importantly, you can ALWAYS talk to a lawyer. And if you ever have any doubt about the legality of a situation, you absolutely SHOULD ask your corporate counsel about what is going on. 

In closing, if an agent asks you not to tell someone about a conversation, it’s a request, not an order. You’re free to tell anyone in the world that you were contacted by the government.

Talking about the substance of your interaction with the government is more worrisome, and I’d limit that conversation with counsel.

I’m a huge fan of Natalie Merchant and 10,000 Maniacs. But if she showed up as a government agent saying, “Don’t talk, I will listen,” I would disregard her request and remain silent. And I would immediately contact counsel and tell them about my visit from Agent Merchant. 

Facebook
Twitter
LinkedIn

David M. Glaser, Esq.

David M. Glaser is a shareholder in Fredrikson & Byron's Health Law Group. David assists clinics, hospitals, and other health care entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David's goal is to explain the government's enforcement position, and to analyze whether this position is supported by the law or represents government overreaching. David is a member of the RACmonitor editorial board and is a popular guest on Monitor Mondays.

Related Stories

Transparency in Coverage Final Rule

Transparency in Coverage Final Rule

The healthcare industry’s landscape shifted dramatically with the implementation of the Transparency in Coverage (TiC) Final Rule. For compliance professionals navigating this regulatory terrain, understanding

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24